1 SEC 13D/G filing tracked · Last updated Sep 29, 2026
$ACXP ACXP - Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile In…